Higher-THC products linked to psychiatric adverse events

Anxiety, psychotic disorder and paranoia lead adverse reactions for THC-predominant medicinal cannabis products, new analysis of TGA data finds Medicinal cannabis products that are Category 5, containing less than 2% cannabidiol and comprising predominantly THC, are behind an influx in psychiatric-related adverse event reports linked to the drugs, a new study has found. Monash University